CTH-501

N/A

Report date: 2025/09/05 17:57:18

Base Information

Drug NameCTH-501
Drug Alias NameCTH-501
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > Natural killer cell therapy > Chimeric antigen receptor NK cell therapyCell and gene therapy > Cell therapy > Stem cell therapy > Induced pluripotent stem cells therapy
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsEndometriosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCartherics Pty Ltd
China Registration ClassN/A

Develop Information

Active CompaniesCartherics Pty Ltd
Inactive CompaniesN/A
Active IndicationsEndometriosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A